Modera Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.19M | Sell |
19,624
-705
| -3% | -$41.1K | 0.01% | 305 |
|
|
2025
Q4 | $1.1M | Sell |
20,329
-445
| -2% | -$21.4K | 0.01% | 325 |
|
|
2025
Q3 | $937K | Sell |
20,774
-4,884
| -19% | -$228K | 0.01% | 348 |
|
|
2025
Q2 | $1.19M | Sell |
25,658
-639
| -2% | -$31.4K | 0.01% | 311 |
|
|
2025
Q1 | $1.6M | Sell |
26,297
-612
| -2% | -$35.7K | 0.02% | 268 |
|
|
2024
Q4 | $1.52M | Sell |
26,909
-3,648
| -12% | -$204K | 0.02% | 275 |
|
|
2024
Q3 | $1.58M | Buy |
30,557
+1,359
| +5% | +$63.8K | 0.02% | 258 |
|
|
2024
Q2 | $1.21M | Sell |
29,198
-77,625
| -73% | -$3.47M | 0.02% | 271 |
|
|
2024
Q1 | $5.79M | Sell |
106,823
-12,901
| -11% | -$657K | 0.09% | 146 |
|
|
2023
Q4 | $6.14M | Sell |
119,724
-45,589
| -28% | -$2.39M | 0.1% | 135 |
|
|
2023
Q3 | $9.59M | Sell |
165,313
-23,329
| -12% | -$1.43M | 0.18% | 107 |
|
|
2023
Q2 | $12.1M | Buy |
188,642
+174,768
| +1,260% | +$11.7M | 0.22% | 90 |
|
|
2023
Q1 | $962K | Sell |
13,874
-290
| -2% | -$20.5K | 0.04% | 160 |
|
|
2022
Q4 | $1.02M | Buy |
14,164
+874
| +7% | +$65.9K | 0.04% | 151 |
|
|
2022
Q3 | $945K | Buy |
13,290
+123
| +0.9% | +$8.92K | 0.05% | 140 |
|
|
2022
Q2 | $1.01M | Buy |
13,167
+2,521
| +24% | +$192K | 0.05% | 143 |
|
|
2022
Q1 | $777K | Buy |
10,646
+1,047
| +11% | +$70.3K | 0.03% | 172 |
|
|
2021
Q4 | $598K | Sell |
9,599
-1,077
| -10% | -$63.2K | 0.02% | 244 |
|
|
2021
Q3 | $632K | Buy |
10,676
+3,430
| +47% | +$226K | 0.03% | 137 |
|
|
2021
Q2 | $484K | Sell |
7,246
-2,022
| -22% | -$132K | 0.03% | 150 |
|
|
2021
Q1 | $585K | Sell |
9,268
-2,809
| -23% | -$175K | 0.04% | 129 |
|
|
2020
Q4 | $749K | Buy |
12,077
+3,433
| +40% | +$211K | 0.06% | 116 |
|
|
2020
Q3 | $521K | Hold |
8,644
| – | – | 0.08% | 85 |
|
|
2020
Q2 | $508K | Sell |
8,644
-2,394
| -22% | -$143K | 0.08% | 83 |
|
|
2020
Q1 | $615K | Buy |
11,038
+742
| +7% | +$45.4K | 0.13% | 70 |
|
|
2019
Q4 | $661K | Buy |
10,296
+1,111
| +12% | +$63.6K | 0.1% | 67 |
|
|
2019
Q3 | $466K | Buy |
9,185
+2,047
| +29% | +$96.2K | 0.08% | 77 |
|
|
2019
Q2 | $324K | Buy |
7,138
+1,700
| +31% | +$79.2K | 0.06% | 100 |
|
|
2019
Q1 | $259K | Sell |
5,438
-129
| -2% | -$6.43K | 0.05% | 117 |
|
|
2018
Q4 | $289K | Buy |
5,567
+229
| +4% | +$12.3K | 0.06% | 97 |
|
|
2018
Q3 | $331K | Sell |
5,338
-830
| -13% | -$49.3K | 0.07% | 94 |
|
|
2018
Q2 | $341K | Sell |
6,168
-252
| -4% | -$13.6K | 0.07% | 90 |
|
|
2018
Q1 | $406K | Buy |
6,420
+1,190
| +23% | +$76.6K | 0.08% | 77 |
|
|
2017
Q4 | $320K | Buy |
5,230
+2
| +0% | +$125 | 0.07% | 94 |
|
|
2017
Q3 | $333K | Sell |
5,228
-143
| -3% | -$8.35K | 0.08% | 88 |
|
|
2017
Q2 | $299K | Buy |
5,371
+2
| +0% | +$109 | 0.07% | 89 |
|
|
2017
Q1 | $292K | Buy |
+5,369
| New | +$294K | 0.07% | 94 |
|
|
2016
Q3 | – | Sell |
-3,123
| Closed | -$230K | – | 113 |
|
|
2016
Q2 | $230K | Sell |
3,123
-232
| -7% | -$16.4K | 0.08% | 88 |
|
|
2016
Q1 | $214K | Sell |
3,355
-5,239
| -61% | -$330K | 0.07% | 100 |
|
|
2015
Q4 | $591K | Buy |
+8,594
| New | +$568K | 0.23% | 33 |
|
|
2015
Q3 | – | Sell |
-3,206
| Closed | -$213K | – | 76 |
|
|
2015
Q2 | $213K | Buy |
+3,206
| New | +$211K | 0.08% | 78 |
|
|
2014
Q1 | – | Sell |
-10,274
| Closed | -$546K | – | 69 |
|
|
2013
Q4 | $546K | Buy |
10,274
+2,030
| +25% | +$103K | 0.21% | 42 |
|
|
2013
Q3 | $382K | Hold |
8,244
| – | – | 0.18% | 37 |
|
|
2013
Q2 | $368K | Buy |
+8,244
| New | +$358K | 0.19% | 37 |
|
Other funds holding BMY
VCM
VPM
Modera Wealth Management's BMY Position: Q1 2026 in Review
Modera Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 3.5% in Q1 2026, selling an estimated $41.1K and leaving 19,624 shares worth $1.19M. The position accounts for 0.01% of the portfolio, ranked #305.
Modera Wealth Management first reported a position in BMY in Q2 2013 and has held it in 44 quarters since. The position peaked at $12.1M in Q2 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Modera Wealth Management held 19,624 shares of Bristol-Myers Squibb worth $1.19M as of Q1 2026.
- Modera Wealth Management sold 705 Bristol-Myers Squibb shares in Q1 2026, an estimated $41.1K.
- Bristol-Myers Squibb made up 0.01% of Modera Wealth Management's portfolio in Q1 2026, its #305 holding.
- Modera Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 44 quarters since.
- Modera Wealth Management's Bristol-Myers Squibb position peaked at $12.1M in Q2 2023.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Modera Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.